GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Cash Flow from Financing

Raia Drogasil (BSP:RADL3) Cash Flow from Financing : R$-253 Mil (TTM As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2025, Raia Drogasil paid R$0 Mil more to buy back shares than it received from issuing new shares. It spent R$124 Mil paying down its debt. It paid R$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received R$0 Mil from paying cash dividends to shareholders. It spent R$0 Mil on other financial activities. In all, Raia Drogasil spent R$124 Mil on financial activities for the three months ended in Mar. 2025.


Raia Drogasil Cash Flow from Financing Historical Data

The historical data trend for Raia Drogasil's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Cash Flow from Financing Chart

Raia Drogasil Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.01 -1,195.22 467.67 323.27 -383.99

Raia Drogasil Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -455.32 -16.24 -367.06 454.62 -324.31

Raia Drogasil Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Raia Drogasil's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Raia Drogasil's Cash from Financing for the quarter that ended in Mar. 2025 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-253 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (BSP:RADL3) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Raia Drogasil's issuance of stock for the three months ended in Mar. 2025 was R$0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Raia Drogasil's repurchase of stock for the three months ended in Mar. 2025 was R$0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Raia Drogasil's net issuance of debt for the three months ended in Mar. 2025 was R$-124 Mil. Raia Drogasil spent R$124 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Raia Drogasil's net issuance of preferred for the three months ended in Mar. 2025 was R$0 Mil. Raia Drogasil paid R$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Raia Drogasil's cash flow for dividends for the three months ended in Mar. 2025 was R$0 Mil. Raia Drogasil received R$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Raia Drogasil's other financing for the three months ended in Mar. 2025 was R$-0 Mil. Raia Drogasil spent R$0 Mil on other financial activities.


Raia Drogasil Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.

Raia Drogasil Headlines

No Headlines